Fig. 2From: Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagusFreedom from relapse. Patients at risk: Carboplatin/ Paclitaxel - 14.5, 6,1.5. Cisplatin/ 5-fluoruracil - 22.5, 16, 8, 3, 0.5.Back to article page